BIGNOPE
Ko-fi

FDA food · drug · device recalls, merged

Before you eat it, take it, or plug it in — check.

Big Nope pulls three separate FDA recall feeds into one list per state, so you’re not searching three government databases to get one answer.

Just announced

Straight from FDA press releases — not yet formally classified or risk-graded

Recalls nationwide

Data last updated: September 6, 2026 at 11:49 PM UTC

19,229 recalls found
Wording
Class IIILow risk
DrugRecalled August 16, 2023

Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03

Failed dissolution specifications: below specification results at stability 12-month

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-1143-2023
Lot/product code:
Lot# 1904872, Exp 1/31/2025; 1950377, Exp 6/30/2025
Recalling firm:
Esperion
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled August 17, 2023

Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactured by: Patheon, Cincinnati, OH 45237, NDC 67386-211-65

Cross contamination with other products

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-1142-2023
Lot/product code:
Lot#: 3207333A, 3207334A, Exp 03/2027; 3214707A, 3214709A, 3214710A, Exp 02/2028 .
Recalling firm:
Lundbeck LLC
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled September 22, 2023

Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. NDC: 0054-8550-25

Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0066-2024
Lot/product code:
Lot, expiry: Lot AB7486B, exp Dec 2023; Lot AB8766B, exp April 2024; Lot AB9484B, exp Aug 2024
Recalling firm:
West-Ward Columbus Inc
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled October 17, 2023

Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11

Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0088-2024
Lot/product code:
Lot # 1187435 exp date: 02/2024
Recalling firm:
AbbVie Inc.
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled October 20, 2023

Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11

Weaker than it should be Drug: Lower potency than labeled.

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0094-2024
Lot/product code:
Lot 22W02, Exp 01/31/2025
Recalling firm:
Zyla Life Sciences US Inc.
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled November 10, 2023

Tropicamide 1% (10mg/mL), Cyclopentolate 1% (10mg/mL), Phenylephrine 2.5% (25mg/mL), Ketorolac 0.5% (5mg/mL), 5 mL bottles, For Topical Ophthalmic Use Only, Not for IV Use, This is a Compounded Drug, Hospital & Office Use Only, Fagron Sterile Services, 8710 E 34th St N Wichita, KS 67226. NDC 71266-8240-01

Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropper

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0125-2024
Lot/product code:
Lot #: C274-000033372, Exp. Date 01-17-2024; C274-000033764, Exp. Date 02-06-2024
Recalling firm:
Fagron Compounding Services
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled November 20, 2023

Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66

Failed Dissolution Specifications

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0149-2024
Lot/product code:
Lot# ME2713; Exp. 02/2025 Lot # MF8286, ML1860; Exp. 04/2025
Recalling firm:
Siegfried Barbera, SL
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled December 26, 2023

Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11

Stronger than it should be drug: Assay results were slightly above specification at the time zero point.

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0257-2024
Lot/product code:
Lot # 1014208, Exp Mar/31/2025
Recalling firm:
Amerisource Health Services LLC
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled January 18, 2024

Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01

Misprint on tablet

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0312-2024
Lot/product code:
Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026
Recalling firm:
Dr. Reddy's Laboratories, Inc.
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled January 18, 2024

Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-05

Misprint on tablet

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0313-2024
Lot/product code:
Lot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026
Recalling firm:
Dr. Reddy's Laboratories, Inc.
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled January 25, 2024

Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton contains 6 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9012-58

Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0322-2024
Lot/product code:
Lot #: 100040731, Exp 7/31/2024
Recalling firm:
Teva Pharmaceuticals USA, Inc
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled January 25, 2024

Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67

Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0321-2024
Lot/product code:
Lot #: 100042978, Exp 7/31/2024
Recalling firm:
Teva Pharmaceuticals USA, Inc
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled February 1, 2024

HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 68084-447-01; NDC Unit Dose: 68084-447-11

Failed Impurities/Degradation Specifications: not meeting quality requirements (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0320-2024
Lot/product code:
Lot #: 1012275, Exp 02/28/2025
Recalling firm:
Amerisource Health Services LLC
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled February 20, 2024

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

Defective Container: not meeting quality requirements for weight due to a slow leakage at the 12-month stability timepoint.

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0365-2024
Lot/product code:
Lot #: 119874; Exp 06/30/2025
Recalling firm:
Contract Pharmaceuticals Limited Canada
View official FDA record (opens in a new tab)
Class IIILow risk
DrugRecalled February 20, 2024

Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61

Defective Container: not meeting quality requirements for weight due to a slow leakage at the 12-month stability timepoint.

ALL 50 STATES
Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
D-0364-2024
Lot/product code:
Lot #: 119466, 119467 Exp 04/2025; 120351 Exp 08/2025; 121712 Exp 11/2025
Recalling firm:
Contract Pharmaceuticals Limited Canada
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES HASHBROWN CASSEROLE, ALLERGENS: MILK, WHEAT, SOY, FISH, PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the label does not list the ingredients for their products.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1138-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES PEACH PIE INGREDIENTS: PEACH PIE FILLING, SUGARS, VANILLA, BLEACHED FLOUR, SPICES, CONTAINS: WHEAT PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the label fails list any sub ingredients.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1141-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES STRAWBERRY PIE INGREDIENTS: STRAWBERRY PIE FILLING, SUGARS, VANILLA, BLEACHED FLOUR, SPICES, CONTAINS: WHEAT PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the product label fails to list any sub ingredients.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1145-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES GREEN BEAN CASSEROLE, CONTAINS: MILK, SOY, FISH, WHEAT, PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the label does not list the ingredients for their products.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1137-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES SQUASH CASSEROLE CONTAINS: MILK, EGGS, SOY, FISH, WHEAT PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the product label fails to list any ingredients.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1144-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES CHERRY PIE INGREDIENTS: CHERRY PIE FILLING, SUGARS, VANILLA, BLEACHED FLOUR SPICES. CONTAINS: WHEAT PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the label does not list the sub ingredients for their products.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1134-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES SWEET POTATO CASSEROLE CONTAINS: EGG, MILK PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the product label fails to list any ingredients.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1146-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES DOT'S POTATO BAKE 2lb INGREDIENTS: IDAHO POTATOES, MONT JACK, CHEDDAR, SHARP CHEEDAR, & CREAM CHEESES. SOUR CREAM, CHICKEN BROTH, BUTTER, CHIVES, SPICES. CONTAINS: MILK, SOY, FISH PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the label fails to list any sub ingredients.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1142-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES Broccoli Casserole Contains: Wheat, Eggs, Milk, Soy, Fish PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the label does not list any ingredients in the product.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1133-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)
Class IIILow risk
FoodRecalled March 26, 2024

PIES & SIDES CONNIE'S CARAMEL APPLE PIE 11 oz INGREDIENTS: APPLE PIE FILLING, SUGARS, VANILLA, CARAMEL EXTRACT BLEACHED FLOUR, SPICES, CONTAINS: WHEAT, PIES & SIDES MOUNT HOLLY, NC

During an inspection by NCDA, the firm was notified that the label does not list the sub ingredients for their products.

Full report

A low-risk recall. This product is unlikely to cause any health problems, but it still doesn't meet FDA rules.

Recall #:
F-1135-2024
Lot/product code:
All lots shipped before 2/23/2024
Recalling firm:
Robeson Enterprises
View official FDA record (opens in a new tab)